Advances in Care and Outcomes for Children with Cystic Fibrosis

Clin Chest Med. 2024 Sep;45(3):625-637. doi: 10.1016/j.ccm.2024.03.006. Epub 2024 Apr 30.

Abstract

The landscape of care for children with cystic fibrosis (CF), a genetic disorder of chloride transport with multisystem manifestations including inspissated mucus, recurrent sinopulmonary infections, obstructive lung disease, and exocrine pancreatic insufficiency, is rapidly changing. Early diagnosis via newborn screening enabling timely nutritional support, chronic therapies to improve mucociliary clearance, and prompt treatment of pulmonary infections have improved overall outcomes in children with CF. More widespread availability of novel cystic fibrosis transmembrane conductance regulator modulator therapies for children continues to revolutionize pediatric CF care.However, significant challenges exist to optimize care and outcomes for all children with CF.

Keywords: CFTR modulator; CRMS; Cystic fibrosis; Newborn screening; Pediatrics.

Publication types

  • Review

MeSH terms

  • Child
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / diagnosis
  • Cystic Fibrosis* / physiopathology
  • Cystic Fibrosis* / therapy
  • Humans
  • Infant, Newborn
  • Neonatal Screening

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator